USE OF BROMOPHENOL-PYRAZOLINE COMPOUNDS IN THE TREATMENT OF PORCINE CORONAVIRUS DISEASES
申请人:Shandong Linghai Biotechnology Co., Ltd.
公开号:EP4014975A1
公开(公告)日:2022-06-22
The invention belongs to the technical field of medicine, and particularly relates to use of bromophenol-pyrazoline compounds in the treatment of porcine coronavirus diseases. Through the research in the invention, it is found that the bromophenol-pyrazoline compounds inhibit replication of porcine coronaviruses at a cellular level, and can treat porcine coronavirus diseases (such as PEDV and TGEV) in clinical trials, greatly improving the survival rate of infected piglets, so the compounds can be used to prepare drugs for treating porcine coronavirus diseases.
本发明属于医药技术领域,尤其涉及溴酚吡唑啉化合物在治疗猪冠状病毒疾病中的用途。通过本发明的研究发现,溴酚吡唑啉化合物在细胞水平上抑制猪冠状病毒的复制,在临床上可以治疗猪冠状病毒病(如PEDV和TGEV),大大提高了感染仔猪的存活率,因此该化合物可用于制备治疗猪冠状病毒病的药物。